HYDROXYZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroxyzine Hydrochloride patents expire, and what generic alternatives are available?
Hydroxyzine Hydrochloride is a drug marketed by Altana, Am Regent, Baxter Hlthcare, Dr Reddys, Fresenius Kabi Usa, Hospira, Pharmafair, Smith And Nephew, Solopak, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, Anima, Apozeal Pharms, Chartwell Rx, Hikma, Kv Pharm, Lannett Co Inc, Pai Holdings Pharm, Able, Actavis Elizabeth, Amneal Pharm, Aurobindo Pharma Ltd, Epic Pharma Llc, Graviti Pharms, Halsey, Heritage Pharma, Hetero Labs Ltd Iii, Invagen Pharms, Ivax Pharms, Kvk Tech, Mutual Pharm, Northstar Hlthcare, Nuvo Pharms Inc, Pliva, Prinston Inc, Purepac Pharm, Quantum Pharmics, Rising, Sandoz, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, and Usl Pharma. and is included in one hundred NDAs.
The generic ingredient in HYDROXYZINE HYDROCHLORIDE is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxyzine Hydrochloride
A generic version of HYDROXYZINE HYDROCHLORIDE was approved as hydroxyzine hydrochloride by CHARTWELL RX on April 12th, 1982.
Summary for HYDROXYZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 45 |
NDAs: | 100 |
Finished Product Suppliers / Packagers: | 35 |
Raw Ingredient (Bulk) Api Vendors: | 204 |
Clinical Trials: | 32 |
Patent Applications: | 4,575 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDROXYZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for HYDROXYZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sultan Qaboos University | Phase 4 |
Minia University | Phase 1 |
Mongi Slim Hospital | N/A |
Pharmacology for HYDROXYZINE HYDROCHLORIDE
Drug Class | Antihistamine |
Mechanism of Action | Histamine Receptor Antagonists |